Purchase Order 75F40119P10489
Award Date
9/5/19
Potential Completion Date
12/3/24
Potential Value
$62K
Federal Agency
Food and Drug Administration
Awardee
Curi Bio Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98195, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $172,800.00 firm fixed price purchase order to Curi Bio Inc., a for-profit small disadvantaged business, for the acquisition of a Mantarray Magnetometric Analyzer for Engineered Tissue Arrays. This specialized equipment will be used to support biomedical research programs within the NIH, including efforts to develop human cell-based platforms for drug discovery...
This $17,020 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Curi Bio Inc., a small disadvantaged business manufacturer. The contract is for the delivery of 3D IPSC skeletal muscle media kits, which will support biomedical research and drug development programs at NCATS. Curi Bio has previously received other federal contracts and grants from the National...
<p>The Department of Health and Human Services Food and Drug Administration awarded a $175,000.00 firm fixed price purchase order to Cytobioscience, Inc., a for-profit organization, to upgrade the agency's in-house automated patch clamp system. The contract was awarded on September 2, 2018, with a completion date of November 30, 2018. The contract was not set aside for any specific socioeconomic category.</p>
This federal contract award from the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned for-profit manufacturer, is for the provision of human induced pluripotent stem derived cardiomyocytes. The $84,500.00 firm-fixed-price purchase order contract has a period of performance through March 20, 2017. The contract is not set aside for small businesses. Fujifilm Cellular Dynamics is a key supplier of specialized and proprietary human cell lines, including diverse...
This federal contract award, valued at $23,850.00, was issued by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract is designated as a Total Small Business set-aside and is for the delivery of CARDIOMYOCYTES, which are specialized cardiac muscle cells. Fujifilm Cellular Dynamics has a strong track record of supplying diverse...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $17,760 firm fixed price purchase order to Curiox Biosystems Inc. of San Carlos, California. The period of performance for this contract is August 11, 2017 through August 10, 2018. Curiox Biosystems Inc. will serve as the prime contractor, providing unspecified products or services to NIH/NICHD in support of their research efforts. No major...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract has a ceiling value of $119,350.00 and is not set aside for small businesses. The contract is for the supply of "MYCELL AND ICELL...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The $11,940 contract is for the supply of cardiomyocytes (heart muscle cells) and does not have a small business set-aside designation. Fujifilm Cellular Dynamics has been a consistent provider of specialized cell products to various federal agencies,...
This is a $99,500.00 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The contract is for the supply of iCell Cardiomyocytes, a specialized cell product used in biomedical research, drug development, and toxicology screening. The contract has...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cell lines. The $79,500.00 contract is for the supply of human iPSC-derived cardiomyocytes (heart muscle cells) to support biomedical research, drug development, and toxicology screening initiatives. The...